How many insider trades does FilingIQ track for BMEA?

FilingIQ tracks 60 Form 4 insider transactions for BMEA (Biomea Fusion, Inc.), covering filings from Apr 15, 2021 onwards. 2 of those were filed in the last 90 days.

Are BMEA insiders net buyers or net sellers?

Across the full Form 4 history for BMEA, 25 transactions (42%) were open-market purchases and 10 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does BMEA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is BMEA in?

Biomea Fusion, Inc. (BMEA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $95.44M.

BMEA insider trading

NasdaqGS Healthcare

Biomea Fusion, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

42% / 17%

Market cap

$95.44M

About Biomea Fusion, Inc.

Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States. It's lead product candidate icovamenib, an orally bioavailable, potent, and covalent inhibitor of menin, a ubiquitously expressed scaffold protein that functions in histone modification and epigenetic gene regulation to impact multiple cellular processes including cell cycle control, apoptosis, and DNA damage repair. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in San Carlos, California.

Company website: biomeafusion.com

BMEA insider activity at a glance

FilingIQ has scored 60 insider transactions for BMEA since Apr 15, 2021. The most recent filing in our index is dated Apr 1, 2026.

Across the full history, 25 open-market purchases and 10 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BMEA insider trades is 52.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live BMEA trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding BMEA

Ikarian Capital, LLC

$16.11M · 1.8% of AUM

Frequently asked

How many insider trades does FilingIQ track for BMEA?: FilingIQ tracks 60 Form 4 insider transactions for BMEA (Biomea Fusion, Inc.), covering filings from Apr 15, 2021 onwards. 2 of those were filed in the last 90 days.
Are BMEA insiders net buyers or net sellers?: Across the full Form 4 history for BMEA, 25 transactions (42%) were open-market purchases and 10 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BMEA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is BMEA in?: Biomea Fusion, Inc. (BMEA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $95.44M.

Methodology & sources

Every BMEA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.